Inactive Instrument

Veritas Pharma Inc Stock Other OTC

CA92347A1066

Latest news : Veritas Pharma Inc

04/05/23	Indigenous Bloom Hemp Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2023	CI
30/01/23	Indigenous Bloom Hemp Corp. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2022	CI
05/12/22	Indigenous Bloom Hemp Corp. Reports Earnings Results for the First Quarter Ended August 31, 2022	CI
01/12/22	Indigenous Bloom Hemp Corp. Announces Board Resignations	CI
01/12/22	Indigenous Bloom Hemp Corp. Announces Resignation of Peter McFadden as CFO	CI
28/11/22	Indigenous Bloom Hemp Corp. Auditor Raises 'Going Concern' Doubt	CI
28/11/22	Indigenous Bloom Hemp Corp. Reports Earnings Results for the Full Year Ended May 31, 2022	CI
16/08/22	Indigenous Bloom Hemp Corp Provides Update on Final Joint Venture Agreement with Dykstra Greenhouses	CI
08/08/22	Indigenous Bloom Hemp Corp. Appoints Chris Federowich to its Board of Directors	CI
06/05/22	Indigenous Bloom Hemp Corp. Announces Director Change	CI
03/05/22	Indigenous Bloom Hemp Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022	CI
03/05/22	Indigenous Bloom Hemp Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022	CI
29/04/22	Indigenous Bloom Hemp Corporation Announces Strategic Joint Venture to Accelerate Their Cannabis Product Operations	CI

More news

Press Releases: Veritas Pharma Inc

06/10/23	Canadian Investment Regulatory Organization Trading Halt - IBH	AQ
10/12/21	IIROC Trade Resumption - IBH	AQ
16/09/21	Veritas Pharma : IIROC Trading Halt - VRT	AQ
09/09/21	CSE Bulletin: Reinstatement - Veritas Pharma Inc. (VRT)	NE
09/09/21	Veritas Pharma : IIROC Trade Resumption - VRT	AQ

More press releases

Managers and Directors: Veritas Pharma Inc

Manager	Title	Age	Since
Lorne Roseborough CEO	Chief Executive Officer	73	01/04/2021
Peter McFadden CEO	Chief Executive Officer	-	11/02/2019

Director	Title	Age	Since
Lorne Roseborough CHM	Chairman	73	24/04/2020
Sharon Blady BRD	Director/Board Member	-	24/04/2020
Larry Dykstra BRD	Director/Board Member	-	06/05/2022

More insiders

Veritas Pharma Inc is a Canada-based emerging pharmaceutical and Intellectual Property (IP) development company. The Company's objective is, through its investment in Cannevert Therapeutics Ltd (CTL), to develop cannabis strains (cultivars) specific to chronic pain, such as cancer pain, nausea and vomiting, epilepsy, muscle spasms and Post-Traumatic Stress Disorder (PTSD), solving the critical need for clinical data to support medical marijuana claims. Veritas Pharma Inc's commercial mission is to patent protect IP (cultivars and strains) and sell or license to cancer clinics, insurance industry and pharma. Its research and development approach objective is to solve the critical need for real science to support claims surrounding medical marijuana. Its scientific approach combined with its strategic alliances, addresses the concerns over the medical industry's varied output in content, quality, potency and efficacy.

Employees

Sector

More about the company